Eleven medical organizations advised changes to preventive cardiac care that it says could markedly reduce heart attacks and strokes.

Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030 Vancouver, Cana ...

Following rivals like Amazon and OpenAI, Microsoft is upgrading its artificially intelligent assistant to track your health. There are benefits and risks to consider.

Clearmind Medicine Inc. (Nasdaq: CMND) ("Clearmind" or the "Company"), a clinical-stage biotech company focused on the discovery and development ...

Immune system cells can be engineered outside of the body in a type of therapy called CAR-T. Now, Johns Hopkins scientists are developing ways to sidestep such cell manufacturing with a biodegradable ...